Alcidion (ASX:ALC) renews ACT Health contract

Company News

by Katrina Bullock

Biotech company Alcidion Group (ASX:ALC) has renewed its ongoing support services contract with ACT Health for an additional 2 years.

The contract extension is valued at $1.3 million and effective from 1 January 2021.

It relates to the provision of integrated patient management system services.

Managing Director of Alcidion, Kate Quirke, says the company is “proud of [its] longstanding relationship with ACT Health and look[s] forward to providing ongoing technical support services that will support ACT Health’s ongoing commitment to providing highly integrated healthcare across all its facilities in Canberra”.

Shares in Alcidion Group (ASX:ALC) are trading 3.3 per cent higher at $0.15.

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.